academic article

• Nisbet I. Cancer immunotherapy comes of age (Finally!).  Australasian Biotechnology.  26:38-40. 2016
  
• Nisbet I. Biodiscovery of rich source of drug-like potent molecules-venom peptides.  Industrial Bioprocessing.  30:8-9. 2008
  
• Nisbet I. The pharmaceutical forecast.  Australian Life Scientist.  2:16. 2005
  
• Woodrow GCNisbet ICorbett ME. Australia: Ready for business.  Nature Biotechnology.  15:731-732. 1997
  Full text if available
• Webb ETkalcevic JEdwards SHocking DNisbet I. Enhanced secretory ability for the human factor VIII light chain produced in baculovirus-infected insect cells.  Cytotechnology: international journal of cell culture and biotechnology.  21:165-170. 1996
  Full text if available
• Jagadish MNEdwards SJHayden MBGrusovin JVandenberg KSchoofs PHamilton RCShukla DDKalnins HMcNamara MHaynes JNisbet ITWard CWPye D. Chimeric Potyvirus-Like Particles as Vaccine Carriers.  Intervirology: international journal of basic and medical virology.  39:85-92. 1996
  Full text if available
• Ba-Thein WLyristis MOhtani KNisbet ITHayashi HRood JIShimizu T. The virR/virS locus regulates the transcription of genes encoding extracellular toxin production in Clostridium perfringens..  Journal of Bacteriology.  178:2514-2520. 1996
  Full text if available
• Edwards SJHayden MBHamilton RCHaynes JANisbet ITJagadish MN. High level production of potyvirus-like particles in insect cells infected with recombinant baculovirus.  Archives of Virology.  136:375-380. 1994
  Full text if available
• Lyristis MBryant AESloan JAwad MMNisbet ITStevens DLRood JI. Identification and molecular analysis of a locus that regulates extracellular toxin production in Clostridium perfringens.  Molecular Microbiology.  12:761-777. 1994
  Full text if available
• Jagadish MNHamilton RCFernandez CSSchoofs PDavern KMKalnins HWard CWNisbet IT. High Level Production of Hybrid Poty virus–like Particles Carrying Repetitive Copies of Foreign Antigens in Escherichia coli.  Biotechnology.  11:1166-1170. 1993
  Full text if available
• Webb ENisbet I. The effect on recombinant protein production of reinstating native introns in the coding sequence of human factor VIII.  Biotechnology Letters.  15:889-894. 1993
  Full text if available
• Haynes JATkalcevic JNisbet IT. Production of an enzymatically inactive analog of phospholipase D from Corynebacterium pseudotuberculosis.  Gene.  119:119-121. 1992
  Full text if available
• Wright IGCasu RCommins MADalrymple BPGale KRGoodger BVRiddles PWWaltisbuhl DJAbetz IBerrie DABowles YDimmock CHayes TKalnins HLeatch GMcCrae RMontague PENisbet ITParrodi FPeters JMScheiwe PCSmith WRode-Bramanis KWhite MA. The development of a recombinant Babesia vaccine.  Veterinary Parasitology.  44:3-13. 1992
  Full text if available
• Glare EMPaton JCPremier RRLawrence AJNisbet IT. Analysis of a repetitive DNA sequence from Bordetella pertussis and its application to the diagnosis of pertussis using the polymerase chain reaction.  Journal of Clinical Microbiology.  28:1982-1987. 1990
  
• Hodgson ALBird PNisbet IT. Cloning, nucleotide sequence, and expression in Escherichia coli of the phospholipase D gene from Corynebacterium pseudotuberculosis..  Journal of Bacteriology.  172:1256-1261. 1990
  Full text if available
• BEILHARZ MANFREDWNISBET IANTTYMMS MARTINJHERTZOG PAULJLINNANE ANTHONYW. Antiviral and Antiproliferative Activities of Interferon-α1: The Role of Cysteine Residues.  Journal of Interferon Research.  6:677-685. 1986
  Full text if available
• Nisbet ITBeilharz MWHertzog PJTymms MJLinnane AW. Single amino acid substititons at conserved residues of human interferon-α can effect antiviral specific activity.  Biochemistry International.  11:301-309. 1985
  
• Nisbet ITBeilharz MW. Simplified DNA manupulations based on in vitro mutagenesis.  Gene Analysis Techniques.  2:23-29. 1985
  Full text if available
• Linnane AWBeilharz MWMcMullen GLMacreadie IGMurphy MNisbet ITNovitski CEWoodrow GC. Nucleotide sequence and expression in E. coli of a human interferon-alpha gene selected from a genomic library using synthetic oligonucleotides..  Biochemistry International.  8:725-732. 1984